Multidisciplinary treatment of synchronous primary rectal and prostate cancers

Nat Clin Pract Oncol. 2005 May;2(5):271-4; quiz 1 p following 274. doi: 10.1038/ncponc0173.

Abstract

Background: A 58-year-old Caucasian man with a history of irritable bowel syndrome and occasional rectal bleeding presented with a 4-week history of progressive, bright red blood per rectum. A digital rectal examination revealed a 3 cm distal, midrectal mass. Laboratory tests showed an elevated serum prostate-specific antigen of 32 ng/ml but other physical and medical examinations were unremarkable.

Investigations: Digital rectal examination, colonoscopy, rectal mass biopsy, endorectal ultrasound, transrectal ultrasound-guided prostate biopsy, CT scan and MRI.

Diagnosis: Clinical stage III (T3N1M0), moderately differentiated adenocarcinoma of the rectum and clinical stage II (T1cN0M0) adenocarcinoma of the prostate.

Management: Intensity-modulated radiation therapy, chemoradiation, chemotherapy, hormone therapy and surgery.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Gastrointestinal Hemorrhage / etiology
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Multiple Primary / pathology*
  • Neoplasms, Multiple Primary / therapy
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / therapy

Substances

  • Antineoplastic Agents, Hormonal